Clinical and Radiographic Outcomes of Alveolar Ridge Preservation (REGSYST)

Clinical and Radiographic Outcomes of Alveolar Ridge Preservation for Implant-prosthetic Rehabilitation in a Hospital Setting: a Prospective Study

Dental implants are considered a predictable rehabilitative option following tooth extraction or in cases of missing teeth. In some situations, the inevitable alveolar ridge resorption that occurs after extraction may make the placement of standard-diameter (>3.5 mm) or standard-length implants difficult or even impossible without advanced bone augmentation procedures. To counteract post-extraction volumetric bone contraction, alveolar ridge preservation can be performed, consisting of placing a bone graft within the socket walls immediately after tooth extraction. Although this procedure cannot completely prevent dimensional changes, it has been shown to significantly reduce both horizontal and vertical ridge resorption, as reported in the scientific literature. However, there is a lack of clinical and radiographic studies evaluating the outcomes of implant rehabilitation following alveolar ridge preservation with standard-dimension implants in a hospital-based setting.

Study Overview

Status

Not yet recruiting

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients aged 18 years and older requiring bone regeneration with an alveolar ridge preservation technique prior to implant rehabilitation will be included in the study.

Description

Inclusion Criteria:

  • Patients requiring alveolar ridge preservation procedures prior to implant rehabilitation of edentulous sites;
  • Age > 18;
  • Achievement of FMPS and FMBS ≤ 15%;
  • Signed written informed consent to participate in the study.

Exclusion Criteria:

  • Uncontrolled diabetes or hypertension;
  • Uncontrolled periodontal disease;
  • Inability to perform consistent and continuous follow-up;
  • Pregnancy or breastfeeding;
  • Inability to provide written informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Alveolar ridge preservation
Patients aged 18 years and older requiring tooth extraction followed by alveolar ridge preservation to enable implant surgery and prosthetic rehabilitation of edentulous sites.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Volumetric analysis
Time Frame: From tooth extraction to 6 months of follow up.
The dimensional change of hard tissues following bone regenerative procedures will be assessed radiographically by measuring horizontal and vertical bone resorption through CBCT comparison in patients treated in a hospital-based setting.
From tooth extraction to 6 months of follow up.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Esthetic evaluation
Time Frame: From tooth extraction to 5 years of follow-up
Assessed using the PES/WES esthetic index. Scores range from 0 to 14 for the PES and from 0 to 10 for the WES, with higher scores indicating better esthetic outcomes.
From tooth extraction to 5 years of follow-up
Implant success rate
Time Frame: From tooth extraction to 5 years of follow up
Absence of biological and technical complications, expressed as a proportion
From tooth extraction to 5 years of follow up
Implant survival rate
Time Frame: From tooth extraction to 5 years follow up
Rate of dental implants remaining in situ, measured as a proportion
From tooth extraction to 5 years follow up
Prosthesis success rate
Time Frame: From tooth extraction to 5 years of follow up
Absence of technical complications, expressed as a proportion
From tooth extraction to 5 years of follow up
Prosthesis survival rate
Time Frame: From tooth extraction to 5 years of follow up
Rate of prostheses remaining in situ, expressed as a proportion
From tooth extraction to 5 years of follow up
Patient-Reported Outcome Measures
Time Frame: From tooth extraction to 5 years of follow up
Recorded using a specifically designed questionnaire and measured with a visual analogue scale (VAS) ranging from 0 to 10, with higher scores indicating better outcomes
From tooth extraction to 5 years of follow up
Diabetes
Time Frame: From tooth extraction to 5 years of follow up
Analysis of the influence of diabetes (assessed as presence/absence) as potential risk factor during follow-up
From tooth extraction to 5 years of follow up
Glycated hemoglobin level
Time Frame: From tooth extraction to 5 years of follow up
Analysis of glycated hemoglobin levels recorded at baseline and during follow-up
From tooth extraction to 5 years of follow up
Complete Blood Count
Time Frame: From tooth extraaction to 5 years of follow up
Analysis of the influence of complete blood count parameters
From tooth extraaction to 5 years of follow up
Histologic analysis
Time Frame: From tooth extraction to 6 months of follow up
Histomorphometric analysis of hard and soft tissues on stained histologic sections (% new bone, residual graft, epithelial thickness, keratin layer thickness, inflammatory infiltrate, collagen organization, and vascular density)
From tooth extraction to 6 months of follow up
Correlation of medications relevant to bone/soft tissue metabolism with implant health
Time Frame: From tooth extraction to 5 years of follow up
Correlation between exposure to medications affecting bone and soft tissue metabolism and peri-implant marginal bone loss (measured in millimeters on standardized periapical radiographs) and implant success (defined as the absence of complications).
From tooth extraction to 5 years of follow up
Correlation between osteoporosis status and implant health
Time Frame: From tooth extraction to 5 years of follow up
Correlation between osteoporosis status (DXA T-score/ICD diagnosis) and peri-implant marginal bone loss (measured in millimeters on standardized periapical radiographs) and implant success (defined as the absence of complications).
From tooth extraction to 5 years of follow up
Correlation between cardiovascular disease and implant health
Time Frame: From tooth extraction to 5 years of follow up
Correlation between cardiovascular diseases and peri-implant marginal bone loss (measured in millimeters on standardized periapical radiographs) and implant success (defined as the absence of complications).
From tooth extraction to 5 years of follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Carlo Lajolo, Fondazione Policlinico Universitario A. Gemelli, IRCCS

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2026

Primary Completion (Estimated)

March 1, 2031

Study Completion (Estimated)

March 1, 2031

Study Registration Dates

First Submitted

February 6, 2026

First Submitted That Met QC Criteria

February 16, 2026

First Posted (Actual)

February 23, 2026

Study Record Updates

Last Update Posted (Actual)

March 20, 2026

Last Update Submitted That Met QC Criteria

March 18, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 8085

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alveolar Ridge Preservation

Subscribe